Implementation fidelity to HIV assisted partner services (aPS) during scale-up in western Kenya: a convergent mixed methods study.
Assisted partner services
Contact tracing
Convergent mixed methods
HIV testing
Implementation fidelity
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
19 May 2023
19 May 2023
Historique:
received:
26
12
2022
accepted:
10
05
2023
medline:
22
5
2023
pubmed:
20
5
2023
entrez:
19
5
2023
Statut:
epublish
Résumé
HIV assisted partner services (aPS) is an intervention to improve HIV status awareness among sex and drug-injecting partners of people newly diagnosed with HIV (index clients). Implementation fidelity-the degree to which an intervention is conducted as intended - is critical to effectiveness, but there are limited data about aPS fidelity when delivered by HIV testing service (HTS) providers. We explored factors affecting implementation fidelity to aPS in two high-HIV prevalence counties in western Kenya. We used convergent mixed methods adapting the conceptual framework for implementation fidelity within the aPS scale-up project. This was an implementation study examining scale-up of APS within HTS programs in Kisumu and Homa Bay counties that recruited male sex partners (MSPs) of female index clients. We defined implementation fidelity as the extent to which HTS providers followed the protocol for phone and in-person participant tracing at six expected tracing attempts. Quantitative data were collected from tracing reports in 31 facilities between November 2018 and December 2020, and in-depth interviews (IDIs) were conducted with HTS providers. Descriptive statistics were used to describe tracing attempts. IDIs were analyzed using thematic content analysis. Overall, 3017 MSPs were mentioned of whom 98% (2969/3017) were traced, with most tracing attempts being successful (2831/2969, 95%). Fourteen HTS providers participated in the IDIs-mostly females (10/14, 71%) with a median age of 35 years (range 25-52), who all had post-secondary education (14/14, 100%). The proportion of tracing attempts occurring by phone ranged from 47 to 66%, with the highest proportion occurring on the first attempt and lowest on the sixth attempt. Contextual factors either enhanced or impeded implementation fidelity to aPS. Positive provider attitudes towards aPS and conducive work environment factors promoted implementation fidelity, while negative MSP responses and challenging tracing conditions impeded it. Interactions at the individual (provider), interpersonal (client-provider), and health systems (facility) levels affected implementation fidelity to aPS. As policymakers prioritize strategies to reduce new HIV infections, our findings highlight the importance of conducting fidelity assessments to better anticipate and mitigate the impact of contextual factors during the scale-up of interventions.
Sections du résumé
BACKGROUND
BACKGROUND
HIV assisted partner services (aPS) is an intervention to improve HIV status awareness among sex and drug-injecting partners of people newly diagnosed with HIV (index clients). Implementation fidelity-the degree to which an intervention is conducted as intended - is critical to effectiveness, but there are limited data about aPS fidelity when delivered by HIV testing service (HTS) providers. We explored factors affecting implementation fidelity to aPS in two high-HIV prevalence counties in western Kenya.
METHODS
METHODS
We used convergent mixed methods adapting the conceptual framework for implementation fidelity within the aPS scale-up project. This was an implementation study examining scale-up of APS within HTS programs in Kisumu and Homa Bay counties that recruited male sex partners (MSPs) of female index clients. We defined implementation fidelity as the extent to which HTS providers followed the protocol for phone and in-person participant tracing at six expected tracing attempts. Quantitative data were collected from tracing reports in 31 facilities between November 2018 and December 2020, and in-depth interviews (IDIs) were conducted with HTS providers. Descriptive statistics were used to describe tracing attempts. IDIs were analyzed using thematic content analysis.
RESULTS
RESULTS
Overall, 3017 MSPs were mentioned of whom 98% (2969/3017) were traced, with most tracing attempts being successful (2831/2969, 95%). Fourteen HTS providers participated in the IDIs-mostly females (10/14, 71%) with a median age of 35 years (range 25-52), who all had post-secondary education (14/14, 100%). The proportion of tracing attempts occurring by phone ranged from 47 to 66%, with the highest proportion occurring on the first attempt and lowest on the sixth attempt. Contextual factors either enhanced or impeded implementation fidelity to aPS. Positive provider attitudes towards aPS and conducive work environment factors promoted implementation fidelity, while negative MSP responses and challenging tracing conditions impeded it.
CONCLUSION
CONCLUSIONS
Interactions at the individual (provider), interpersonal (client-provider), and health systems (facility) levels affected implementation fidelity to aPS. As policymakers prioritize strategies to reduce new HIV infections, our findings highlight the importance of conducting fidelity assessments to better anticipate and mitigate the impact of contextual factors during the scale-up of interventions.
Identifiants
pubmed: 37208724
doi: 10.1186/s12913-023-09541-1
pii: 10.1186/s12913-023-09541-1
pmc: PMC10198752
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
511Subventions
Organisme : FIC NIH HHS
ID : D43 TW009580
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW009783
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW010905
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
Implement Sci. 2015 Feb 13;10:23
pubmed: 25884936
J Acquir Immune Defic Syndr. 2018 May 1;78(1):16-19
pubmed: 29406431
AIDS Behav. 2014 Jun;18(6):1054-62
pubmed: 24158487
J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):437-42
pubmed: 22046601
Implement Sci Commun. 2020 Oct 08;1:88
pubmed: 33043302
AIDS. 2018 Jan 14;32(2):233-241
pubmed: 29135576
BMC Health Serv Res. 2020 Jul 6;20(1):617
pubmed: 32631397
AIDS. 2017 Aug 24;31(13):1867-1876
pubmed: 28590326
J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):56-61
pubmed: 33044322
Sex Transm Dis. 2013 Dec;40(12):909-14
pubmed: 24220349
MMWR Recomm Rep. 2008 Nov 7;57(RR-9):1-83; quiz CE1-4
pubmed: 18987617
Lancet HIV. 2017 Feb;4(2):e74-e82
pubmed: 27913227
PLoS One. 2021 Sep 17;16(9):e0257486
pubmed: 34534240
Implement Sci. 2007 Nov 30;2:40
pubmed: 18053122
JMIR Res Protoc. 2021 May 20;10(5):e27262
pubmed: 34014172
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25315
pubmed: 31321915
Sex Transm Dis. 2016 Nov;43(11):690-695
pubmed: 27893598
Res Nurs Health. 2008 Aug;31(4):391-8
pubmed: 18203128
Curr HIV/AIDS Rep. 2016 Apr;13(2):107-15
pubmed: 26879653
AIDS Patient Care STDS. 2016 Nov;30(11):506-511
pubmed: 27849369
Health Educ Res. 2016 Apr;31(2):283-94
pubmed: 26944867
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25307
pubmed: 31321889
Health Serv Res. 2013 Dec;48(6 Pt 2):2134-56
pubmed: 24279835
BMC Health Serv Res. 2022 May 7;22(1):616
pubmed: 35525931